US Patent

US8597681 — Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans

Formulation · Assigned to Mallinckrodt LLC · Expires 2030-12-21 · 5y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects methods for producing stabilized solid dosage form pharmaceutical compositions containing morphinans.

USPTO Abstract

Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

Patent Metadata

Patent number: US8597681
Jurisdiction: US
Classification: Formulation
Expires: 2030-12-21
Drug substance claim: No
Drug product claim: Yes
Assignee: Mallinckrodt LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.